In The Research Briefing:

- The methodological challenges faced in psychedelic clinical trials (and how to fix them)
- Mystical experiences in recreational use associated with improvements in wellbeing
- A novel 5-MeO-DMT formulation proves to be safe in Phase I trial

In The Research Briefing: - The methodological challenges faced in psychedelic clinical trials (and how to fix them) - Mystical experiences in recreational use associated with improvements in wellbeing - A novel 5-MeO-DMT formulation proves to be safe in Phase I trial

Research Briefing, Dec 6: Improving psychedelic trials

Report on Psychedelics is the leading source of independent data and intelligence for the emerging psychedelics industry.

Share Research Briefing, Dec 6: Improving psychedelic trials

Sign up to save your podcasts

Research Briefing, Dec 6: Improving psychedelic trials

Research Briefing, Dec 6: Improving psychedelic trials